Cancers

Hard-to-Treat Cancers Respond to New Therapy

A promising new combination therapy is offering new hope for patients with hard-to-treat cancers. This is thanks to scientists at the Fralin Biomedical Research Institute in Virginia who have identified a potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival. The study could help guide the […]